TY - JOUR
T1 - prm-PASEF-Based Quantification and Isomeric Model for Extended Coverage of Human Plasma Lipidome in Parkinson’s Disease
AU - Baker, Dhanwin
AU - Gonzalez Escamilla, Gabriel
AU - Janitschke, Daniel
AU - Devaux, Yvan
AU - Schröter, Nils
AU - Groppa, Sergiu
AU - Bindila, Laura
N1 - Funding:
This work was financially supported by the BMBF-funded
projects Nr: 031 L0217 A and 16LK0241K to LB and by
curATime project nr: 03ZU1202EB to L.B. D.B. is financed by
the BMBF-funded Project Nr: 031 L0217 A and 16LK0241K
to L.B. DB is a registered PhD student at TransMed program.
Publisher Copyright:
© 2025 The Authors. Published by American Chemical Society
PY - 2025/11/11
Y1 - 2025/11/11
N2 - This study introduces a clinical lipidomics platform leveraging fragment-based quantification on parallel reaction monitoring (PRM)-parallel accumulation serial fragmentation (PASEF) for lipid quantification. An isomeric model, termed “SN regression model”, built on specific PASEF-fragment ion patterns, was developed for the quantification of coeluting sn positional isomers without prior derivatization. This PASEF-isomeric lipidomics aids in the resolution and quantification of 176 lipid isomers coeluting in chromatography and/or ion mobility dimensions, expanding the lipidome quantitative coverage to 481 plasma lipids covering 14 lipid subclasses with CV <40% for 32 plasma replicates. We demonstrated the method’s advantage for clinical research by detailed quantitative lipidomic phenotyping of patients with Parkinson’s disease, enabling the delineation of new biochemical pathways affected by the disorder and stratification of patients. The method’s amenability for high-throughput deep quantitative coverage of highly structurally resolved lipidome has implications for improving the diagnosis and understanding of the distinct metabolic alterations in Parkinson’s disease subgroups and, generally, for disorders associated with lipid dysregulation.
AB - This study introduces a clinical lipidomics platform leveraging fragment-based quantification on parallel reaction monitoring (PRM)-parallel accumulation serial fragmentation (PASEF) for lipid quantification. An isomeric model, termed “SN regression model”, built on specific PASEF-fragment ion patterns, was developed for the quantification of coeluting sn positional isomers without prior derivatization. This PASEF-isomeric lipidomics aids in the resolution and quantification of 176 lipid isomers coeluting in chromatography and/or ion mobility dimensions, expanding the lipidome quantitative coverage to 481 plasma lipids covering 14 lipid subclasses with CV <40% for 32 plasma replicates. We demonstrated the method’s advantage for clinical research by detailed quantitative lipidomic phenotyping of patients with Parkinson’s disease, enabling the delineation of new biochemical pathways affected by the disorder and stratification of patients. The method’s amenability for high-throughput deep quantitative coverage of highly structurally resolved lipidome has implications for improving the diagnosis and understanding of the distinct metabolic alterations in Parkinson’s disease subgroups and, generally, for disorders associated with lipid dysregulation.
UR - https://www.scopus.com/pages/publications/105021243319
UR - https://pubmed.ncbi.nlm.nih.gov/41143626/
U2 - 10.1021/acs.analchem.5c02340
DO - 10.1021/acs.analchem.5c02340
M3 - Article
C2 - 41143626
AN - SCOPUS:105021243319
SN - 0003-2700
VL - 97
SP - 24295
EP - 24305
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 44
ER -